Clinical Role - Payer

Pharmacy Times® is a leader in providing the latest clinical updates, patient counseling tools and innovative solutions to payers, pharmacy benefit managers, formulary chairs and directors, managed care directors, quality assurance directors, and Medicaid/Medicare directors.

The 340B program allows covered entities to stretch scarce federal resources to the furthest extent possible to provide patients in need with comprehensive services.
A recent study found that the US rural mortality penalty is wide and further expanding, which applies to the rural population overall, or all racial/ethnic groups combined, and for non-Hispanic whites, non-Hispanic blacks, and Hispanics individually.
The pharmacy’s mind-set should be “Let’s solve the problem” rather than being defensive and attempting to “win the argument” with a PBM audit. 
Whether agreeing to an asset purchase or stock purchase in the sale of a pharmacy, the buyer must perform due diligence. 
Clinical education, strong data analytics, and collaboration are the key aspects in providing patient support and access to specialty pharmaceutical manufacturers.
Lennartz said it’s important that pharmacists are properly reimbursed for the administration of many common immunizations, including the flu vaccine.
Evidence-based cancer regimens have been shown to result in better outcomes, including longer survival and less toxicity.
According to Good Day Pharmacy, plans change each year, and the best plan in 2020 may not be the best plan for 2021.
Insulin prices are 8 times higher in the United States than 32 other high-income countries combined.
Specialty pharmacies are uniquely positioned to thrive in the era of value-based health care.       
Pharmacy Times® interviewed Nancy Lyons, BSPharm, MBA, CDE, vice president and chief pharmacy officer for Health Mart, and Pete Slone, senior vice president of public affairs for McKesson, on the importance of payment models that reward pharmacists’ commitment to patient services.
During American Pharmacists Month, and as the country uses all available health care resources to address COVID-19, there has never been a better or more important time to grant provider status to pharmacists.